Literature DB >> 15379982

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Jörg Vollmer1, Risini D Weeratna, Marion Jurk, Ulrike Samulowitz, Michael J McCluskie, Paul Payette, Heather L Davis, Christian Schetter, Arthur M Krieg.   

Abstract

Oligodeoxynucleotides (ODN) with unmethylated CpG dinucleotides mimic the immune stimulatory activity of bacterial DNA in vertebrates and are recognized by Toll-like receptor 9 (TLR9). It is also possible to detect immune activation with certain phosphorothioate sequences that lack CpG motifs. These ODN are less potent than CpG ODN and the mechanism by which they stimulate mammalian leucocytes is not understood. We here provide several lines of evidence demonstrating that the effects induced by non-CpG ODN are mediated by TLR9. First, non-CpG ODN could not stimulate cytokine secretion from the splenocytes of TLR9-deficient (TLR9(-/-)) mice. Second, immunization of TLR9(+/+) but not TLR9(-/-) mice with non-CpG ODN enhanced antigen-specific antibody responses, although these were T helper type 2 (Th2)-biased. Third, reactivity to non-CpG ODN could be reconstituted by transfection of human TLR9 into non-responsive cells. In addition, we define a new efficient immune stimulatory motif aside from the CpG dinucleotide that consists of a 5'-TC dinucleotide in a thymidine-rich background. Non-CpG ODN containing this motif induced activation of human B cells, but lacked stimulation of Th1-like cytokines and chemokines. Our study indicates that TLR9 can mediate either efficient Th1- or Th2-dominated effects depending on whether it is stimulated by CpG or certain non-CpG ODN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379982      PMCID: PMC1782571          DOI: 10.1111/j.1365-2567.2004.01962.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  40 in total

Review 1.  CpG motifs in bacterial DNA and their immune effects.

Authors:  Arthur M Krieg
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

2.  Oligodeoxynucleotides without CpG motifs work as adjuvant for the induction of Th2 differentiation in a sequence-independent manner.

Authors:  Kunio Sano; Hidekazu Shirota; Tadashi Terui; Toshio Hattori; Gen Tamura
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

Review 3.  Recent advances in the development of immunostimulatory oligonucleotides.

Authors:  Eugen Uhlmann; Joerg Vollmer
Journal:  Curr Opin Drug Discov Devel       Date:  2003-03

4.  Toll-like receptor 9 mediates CpG-DNA signaling.

Authors:  Tsung-Hsien Chuang; Jongdae Lee; Lois Kline; John C Mathison; Richard J Ulevitch
Journal:  J Leukoc Biol       Date:  2002-03       Impact factor: 4.962

5.  Highly immunostimulatory CpG-free oligodeoxynucleotides for activation of human leukocytes.

Authors:  Jorg Vollmer; Andrea Janosch; Meike Laucht; Zuhair K Ballas; Christian Schetter; Arthur M Krieg
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2002-06

6.  Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.

Authors:  Sandra S Diebold; Tsuneyasu Kaisho; Hiroaki Hemmi; Shizuo Akira; Caetano Reis e Sousa
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.

Authors:  Jörg Vollmer; Risini Weeratna; Paul Payette; Marion Jurk; Christian Schetter; Meike Laucht; Tanja Wader; Sibylle Tluk; Ming Liu; Heather L Davis; Arthur M Krieg
Journal:  Eur J Immunol       Date:  2004-01       Impact factor: 5.532

8.  Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs.

Authors:  Fernanda Elias; Juan Flo; Ricardo A Lopez; Jorge Zorzopulos; Alejandro Montaner; Juan M Rodriguez
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

9.  The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily.

Authors:  Florian Heil; Parviz Ahmad-Nejad; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Tanja Gellert; Harald Dietrich; Grayson Lipford; Kiyoshi Takeda; Shizuo Akira; Hermann Wagner; Stefan Bauer
Journal:  Eur J Immunol       Date:  2003-11       Impact factor: 5.532

10.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Authors:  Eicke Latz; Annett Schoenemeyer; Alberto Visintin; Katherine A Fitzgerald; Brian G Monks; Cathrine F Knetter; Egil Lien; Nadra J Nilsen; Terje Espevik; Douglas T Golenbock
Journal:  Nat Immunol       Date:  2004-01-11       Impact factor: 25.606

View more
  30 in total

Review 1.  Development of TLR9 agonists for cancer therapy.

Authors:  Arthur M Krieg
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 2.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

Review 3.  Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases?

Authors:  P Lenert
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

4.  Targeted nanoparticle delivery overcomes off-target immunostimulatory effects of oligonucleotides and improves therapeutic efficacy in chronic lymphocytic leukemia.

Authors:  Bo Yu; Yicheng Mao; Li-Yuan Bai; Sarah E M Herman; Xinmei Wang; Asha Ramanunni; Yan Jin; Xiaokui Mo; Carolyn Cheney; Kenneth K Chan; David Jarjoura; Guido Marcucci; Robert J Lee; John C Byrd; L James Lee; Natarajan Muthusamy
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

5.  Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Authors:  Wing Ki Cheng; Kathleen Wee; Tobias R Kollmann; Jan P Dutz
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

6.  Dietary deoxynucleic acid induces type 2 T-helper immune response through toll-like receptor 9 in mice.

Authors:  Mariko Nakamoto; Emi Shuto; Toshio Hosaka; Tohru Sakai
Journal:  Eur J Nutr       Date:  2010-12-04       Impact factor: 5.614

7.  Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes.

Authors:  Grace A Ward; Kathy L McGraw; Farnoosh Abbas-Aghababazadeh; Benjamin S Meyer; Amy F McLemore; Nicole D Vincelette; Nghi B Lam; Amy L Aldrich; Najla H Al Ali; Eric Padron; Javier Pinilla-Ibarz; Erico Masala; Valeria Santini; Olivier Kosmider; Michaela Fontenay; Pierre Fenaux; Joseph Johnson; Brooke L Fridley; Alan F List
Journal:  Blood Adv       Date:  2021-04-27

8.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Clin Immunol       Date:  2007-08-28       Impact factor: 3.969

9.  Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.

Authors:  Kei Yasuda; Christophe Richez; Melissa B Uccellini; Rocco J Richards; Ramon G Bonegio; Shizuo Akira; Marc Monestier; Ronald B Corley; Gregory A Viglianti; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

10.  Oligonucleotides suppress PKB/Akt and act as superinductors of apoptosis in human keratinocytes.

Authors:  Stefan Kippenberger; Jutta Müller; Maike Schultz; Annette Dorn; Andreas Bock; Hüseyin Aygün; Diamant Thaçi; Matthias Hofmann; Roland Kaufmann; August Bernd
Journal:  Nucleic Acids Res       Date:  2009-04-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.